Welcome to Crene Biotechnology!

+86-576-88205808

Product :

JTT705 Dalcetrapib

JTT705 Dalcetrapib 211513-37-0
Size Price Stock Quantity
Get Quotation Now Add to Cart Bulk Inquiry
Shipping and handling fee USD40, Free delivery is qualified when the total value of your order exceeds USD500.If the item is temporarily out of stock. Please email to order@pharm-intermediates.com,we will inform you when we have it in stock.
Chemical Information
Product name:JTT705 Dalcetrapib Purity:98% min
CAS NO:211513-37-0 Solubility:DMSO : ≥ 50 mg/mL (128.34 mM)
Molecular Formula:C23H35NO2S Package:Package according to customer requirements
Molecular Weight:389.595 Storage:Store at -20℃
Quality control
Remarks

Dalcetrapib, aslo known as JTT-705, is a CETP inhibitor. The drug was aimed at raising the blood levels of "good cholesterol" (cholesterol carried in HDL particles, aka HDL-C). Prevailing observations indicate that high HDL levels correlate with better overall cardiovascular health, though it remains unclear whether raising HDL levels consequently leads to an increase in cardiovascular health. Development of this drug was halted on May 7, 2012 “due to a lack of clinically meaningful efficacy. 

 

 

 

Related Products:

SRT1720 hcl; Barasertib; ABT-751; MK-5108; SNS-314; SNS-314 mesylate; Alisertib; Abexinostat; Romidepsin; R547; Tubastatin A HCLSCH900776; PF00477736; GW7647

Products are chemical reagents for research use only and are not intended for human use. We do not sell to patients.
Friendly link:

Copyright Copyright (C) 2018-2024 Taizhou Crene Biotechnology Co.,Ltd.  

Address:Economic Developed Zone of Taizhou Zhejiang China